汇聚中西医优势互补的临床证据,提高肝胆胰疾病结合医学诊疗水平

刘平

doi:10.3969/j.issn.1001-5256.2017.05.001

汇聚中西医优势互补的临床证据,提高肝胆胰疾病结合医学诊疗水平

DOI: 10.3969/j.issn.1001-5256.2017.05.001

刘平

上海中医药大学附属曙光医院·肝病研究所,上海高校中医内科学E-研究院,肝肾疾病病证教育部重点实验室

详细信息

中图分类号: R57
计量
- 文章访问数: 302
- HTML全文浏览量: 35
- PDF下载量: 77
- 被引次数: 0
出版历程
- 收稿日期: 2017-04-05
- 出版日期: 2017-05-20

Improving the diagnosis and treatment of hepatobiliary & pancreatic diseases based on clinical evidence of advantages of integrated traditional Chinese and Western medicine

Liu Ping

Institute of Hepatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine & E-institutes of Shanghai Municipal Education Commission & Key Laboratory of Liver and Kidney Diseases

摘要

摘要: 《临床肝胆病杂志》本期中西医结合重点号邀约从事中西医结合肝胆胰疾病临床诊疗专家,紧密结合各自的临床诊疗实践与研究,专题介绍部分肝胆胰疾病诊疗过程中如何充分发挥中西医优势互补切实提高患病人群获益以及发展问题,从一个侧面显现中西医结合发展的前景。
- 中西医结合疗法 /
- 肝疾病 /
- 胆道疾病 /
- 胰腺疾病 /
- 述评
Abstract: This issue of Journal of Clinical Hepatology focuses on integrated traditional Chinese and Western medicine and has invited the experts who are engaged in the diagnosis and treatment of hepatobiliary & pancreatic diseases using integrated traditional Chinese and Western medicine.With reference to their clinical practice of diagnosis and treatment and related studies, the special topics introduce how to give full play to the advantages of both traditional Chinese and Western medicine to improve patients' benefits and related developmental issues and show the perspectives of the development of integrated traditional Chinese and Western medicine.
- TCM WM therapy /
- liver diseases /
- biliary tract diseases /
- pancreatic diseases /
- editorial

HTML全文

参考文献(6)

[1]CONTI F, BUONFIGLIOLI F, SCUTERI A, et al.Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals[J].J Hepatol, 2016, 65 (4) :727-733.

[2]YU YQ, ZHOU Q, FENG DY.Meta analysis on Fuzhenghuayu capsule combined with nucleoside antiviral drug for chronic hepatitis B[J].J Reg Anat Oper Surg, 2012, 21 (1) :24-28. (in Chinese) 余燕青, 周权, 冯德云.扶正化瘀胶囊联合核苷类抗病毒药物治疗慢性乙型肝炎的meta分析[J].局解手术学杂志, 2012, 21 (1) :24-28.

[3]ZHANG RF, BI DM, YOU ZL, et al.Efficiency of Fuzheng Huayu Capsule combined with tenofovir in treatment of hepatitis B liver fibrosis[J].J Third Milit Med Univ, 2016, 38 (21) :2363-2367. (in Chinese) 张瑞凤, 毕东敏, 游忠岚, 等.扶正化瘀胶囊联合替诺福韦治疗乙肝肝纤维化的疗效观察[J].第三军医大学学报, 2016, 38 (21) :2363-2367.

[4]GU C, SONG MY, SUN WJ, et al.Advances in basic and clinical research on liver cirrhosis in 2016[J].Chin J Hepatol, 2017, 25 (1) :5-8. (in Chinese) 古川, 宋美怡, 孙文静, 等.2016年肝硬化领域基础与临床研究进展[J].中华肝脏病杂志, 2017, 25 (1) :5-8.

[5]XIAO DH, GU J, CAI H, et al.A randomized placebo-controlled multicentre study of Fuzhenghuayu capsule for prevention of oesophageal variceal bleeding in patients with liver cirrhosis[J].Chin JHepatol, 2014, 22 (8) :594-599. (in Chinese) 肖定洪, 顾杰, 蔡虹, 等.扶正化瘀胶囊预防肝硬化患者食管静脉曲张破裂出血的随机对照多中心临床研究[J].中华肝脏病杂志, 2014, 22 (8) :594-599.

[6]HU K, ZHAO K, TAN QY.Clinical experience in Danning tablets promoting recovery of gallbladder function after laparoscopic gallbladder-preserving cholecystolithotomy in patients with gallstones[J].Clin J Curr Adv Gen Surg, 2015, 18 (6) :491-493. (in Chinese) 胡魁, 赵凯, 谭群亚.胆宁片促进胆囊结石患者腹腔镜保胆取石术后胆囊功能恢复的临床体会[J].中国现代普通外科进展, 2015, 18 (6) :491-493.

施引文献

资源附件(0)

访问统计